Studies of Cytotoxicity Effects, SARS-CoV-2 Main Protease Inhibition, and in Silico Interactions of Synthetic Chalcones

被引:5
|
作者
Fernandes, Octavio L. Guterres L. [1 ]
Tizziani, Tiago [1 ]
Dambros, Bibiana P. [2 ]
de Sousa, Natalia Ferreira [3 ]
Pontes, Carime Mansur L. [1 ]
da Silva, Layzon A. L. [4 ]
Pollo, Luiz A. Escorteganha A. [4 ]
de Assis, Francisco F. [1 ]
Scotti, Marcus T. [3 ]
Scotti, Luciana [3 ]
Braga, Antonio L. [1 ]
Steindel, Mario [2 ]
Sandjo, Louis P. [1 ]
机构
[1] Univ Fed Santa Catarina, Dept Chem, Postgrad Program Chem, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Fed Paraiba, Dept Pharmaceut Sci, Postgrad Program Nat & Bioact Synthet Prod, BR-50670910 Joao Pessoa, Paraiba, Brazil
[4] Univ Fed Santa Catarina, Dept Pharmaceut Sci, Postgrad Program Pharm, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
关键词
SARS-CoV-2; M-pro; inhibitory effects; heterocyclic chalcones; molecular docking; DERIVATIVES; COVALENT; VOLSURF; MOLDOCK;
D O I
10.1002/cbdv.202201151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 main protease (M-pro) plays an essential role in proteolysis cleavage that promotes coronavirus replication. Thus, attenuating the activity of this enzyme represents a strategy to develop antiviral agents. We report inhibitory effects against M-pro of 40 synthetic chalcones, and cytotoxicity activities, hemolysis, and in silico interactions of active compounds. Seven of them bearing a (E)-3-(furan-2-yl)-1-arylprop-2-en-1-one skeleton (10, 28, and 35-39) showed enzyme inhibition with IC50 ranging from 13.76 and 36.13 mu M. Except for 35 and 36, other active compounds were not cytotoxic up to 150 mu M against THP-1 and Vero cell lines. Compounds 10, and 35-39 showed no hemolysis while 28 was weakly hemotoxic at 150 mu M. Moreover, molecular docking showed interactions between compound 10 and M-pro (PDBID 5RG2 and 5RG3) with proximity to cys145 and His41, suggesting a covalent binding. Products of the reaction between chalcones and cyclohexanethiol indicated that this binding could be a Michael addition type.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Inhibition of the SARS-CoV-2 Main Protease by Isoquercitrin γ-Cyclodextrin Inclusion Complex Formulations: A Biochemical and In Silico Study
    Wurtele, Martin
    Coelho, Camila
    Gallo, Gloria
    Campos, Claudia
    Hardy, Leon
    Perez Castillo, Yunierkis
    Moriwaki, Masamitsu
    Kapoor, Mahendra P.
    de Sousa, Damiao Pergentino
    JOURNAL OF CHEMISTRY, 2023, 2023
  • [22] In silico studies on structural inhibition of SARS-CoV-2 main protease Mpro by major secondary metabolites of Andrographis paniculata and Cinchona officinalis
    Majumdar, Moumita
    Singh, Vishal
    Misra, Tarun Kumar
    Roy, Dijendra Nath
    BIOLOGIA, 2022, 77 (05) : 1373 - 1389
  • [23] In silico studies on structural inhibition of SARS-CoV-2 main protease Mpro by major secondary metabolites of Andrographis paniculata and Cinchona officinalis
    Moumita Majumdar
    Vishal Singh
    Tarun Kumar Misra
    Dijendra Nath Roy
    Biologia, 2022, 77 : 1373 - 1389
  • [24] Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives
    Shellenberger, Blake M.
    Basile, Olivia N.
    Cassel, Joel
    Olsen, Morgan R.
    Salvino, Joseph M.
    Montaner, Luis J.
    Tietjen, Ian
    Henry, Geneive E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 102
  • [25] In silico tuning of binding selectivity for new SARS-CoV-2 main protease inhibitors
    Wang, Feng
    Vasilyev, Vladislav
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2025, 262
  • [26] In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease
    Adrian Josiah T. Cheng
    Stephani Joy Y. Macalino
    Junie B. Billones
    Marilen Parungao Balolong
    Lyre Anni E. Murao
    Maria Constancia O. Carrillo
    Journal of Molecular Modeling, 2022, 28
  • [27] In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro SARS-CoV-2
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    PHARMACEUTICAL SCIENCES, 2020, 26 : S52 - S62
  • [28] Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study
    Hossain, Rajib
    Mahmud, Shafi
    Khalipha, Abul Bashar Ripon
    Saikat, Abu Saim Mohammad
    Dey, Dipta
    Khan, Rasel Ahmed
    Rauf, Abdur
    Wadood, Abdul
    Rafique, Humaria
    Bawazeer, Sami
    Khalil, Anees Ahmed
    Almarhoon, Zainab M.
    Mabkhot, Yahia N.
    Alzahrani, Khalid J.
    Islam, Muhammad Torequl
    Alsharif, Khalaf F.
    Khan, Haroon
    MAIN GROUP CHEMISTRY, 2023, 22 (02) : 313 - 327
  • [29] In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease
    Palanisamy, Kandhan
    Maiyelvaganan, K. Rudharachari
    Kamalakannan, Shanmugasundaram
    Thilagavathi, Ramasamy
    Selvam, Chelliah
    Prakash, Muthuramalingam
    MOLECULAR SIMULATION, 2023, 49 (02) : 175 - 185
  • [30] In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2
    Garg, Saksham
    Roy, Arpita
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 332